f 0870 460 2486

GMS Changes - 1st April 2018

Thursday 12th Apr 2018

QOF 2018/19

Average list size for 2018/19 has risen to 8,096 (was 7,732)

Average value of each QOF point as a result has risen to £179.26 (was £171.20)

1% uplift to pay, 3% uplift to expenses reimbursement

For those practices who list size remain static and the number of patients on each of the disease registers also remain static, you will see a drop in your total QOF income.  For more information on prevalence & QOF Health Check’s don’t hesitate to call us for more information.

No indicators have been removed and there are no changes to thresholds.

 Vaccination & Immunisations

 Changes to the V&I programme from April 2018 include:
Vacs changes

  • Hepatitis B (newborn babies) - name changed to Hepatitis B at-risk (newborn babies). Vaccine changes & number of recommended doses reduced to 3, payment of the 2nd dose has now been uncoupled from the 3rd dose.  This was an in-year changed effective from 30th October 2017.
  • MenACWY 18 years on 31st August - PROGRAMME REMOVED
  • Meningococcal completing dose - cohort extended to include eligible school leavers previously covered by the 18 years programme.  Eligibility now 1st April 2012.
  • Meningococcal B - programme moved in to the SFE but is not included in the childhood targeted programme, there are no changes to eligibility of payment requirements
  • Pneumococcal PCV 3 month dose - removed from the childhood programme (the date this is effective from still to be confirmed). Funding for this completing dose will remain at £15.02 

  The detail above does not include some of the other non-contractual changes which we will detail in future editions.  However, the detail above we believe is the more pertinent detail you need for April 2018.

We use cookies on this website for better user experience.
How we use cookies